Large-scale preparation of recombinant ovine prolactin and determination of its in vitro and in vivo activity

Haim Leibovich, Nina Raver, Asael Herman, Ewa L. Gregoraszczuk, Elisha Gootwine, Arieh Gertler*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Recombinant bovine Ala-prolactin (PRL) (GenBank Accession No. V00112) in prokaryotic expression plasmid pMON3401 was mutated using a mutagenesis kit, to prepare plasmid encoding ovine PRL (oPRL) (Gen-Bank Accession No. M27057) Escherichia coli cells transformed with this latter plasmid overexpressed large amounts of oPRL upon induction with nalidixic acid. The expressed protein, found in inclusion bodies, was refolded and purified to homogeneity on a Q-Sepharose column, yielding an electrophoretically pure fraction composed of over 98% monomeric protein of the expected molecular mass of ∼23 kDa. The biological activity of the recombinant oPRL after proper renaturation was evidenced in vitro by its ability to stimulate proliferation of rat lymphoma Nb2 cells possessing PRL receptors, to stimulate luciferase activity in HEK 293 cells transiently transfected with oPRL receptors, and to induce progesterone secretion in primary cultures of luteal cells obtained from midpregnant ewes. In contrast to ovine growth hormone or ovine placental lactogen, recombinant oPRL had no galactopoietic effect in lactating ewes.

Original languageEnglish
Pages (from-to)489-496
Number of pages8
JournalProtein Expression and Purification
Volume22
Issue number3
DOIs
StatePublished - 2001

Keywords

  • Bioactivity
  • Galactopoiesis
  • Luteotropic effect
  • Ovine
  • Prolactin
  • Recombinant

Fingerprint

Dive into the research topics of 'Large-scale preparation of recombinant ovine prolactin and determination of its in vitro and in vivo activity'. Together they form a unique fingerprint.

Cite this